Synopsis
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Bucillamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bucillamine, including repackagers and relabelers. The FDA regulates Bucillamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bucillamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bucillamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bucillamine supplier is an individual or a company that provides Bucillamine active pharmaceutical ingredient (API) or Bucillamine finished formulations upon request. The Bucillamine suppliers may include Bucillamine API manufacturers, exporters, distributors and traders.
click here to find a list of Bucillamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bucillamine DMF (Drug Master File) is a document detailing the whole manufacturing process of Bucillamine active pharmaceutical ingredient (API) in detail. Different forms of Bucillamine DMFs exist exist since differing nations have different regulations, such as Bucillamine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bucillamine DMF submitted to regulatory agencies in the US is known as a USDMF. Bucillamine USDMF includes data on Bucillamine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bucillamine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bucillamine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Bucillamine Drug Master File in Japan (Bucillamine JDMF) empowers Bucillamine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Bucillamine JDMF during the approval evaluation for pharmaceutical products. At the time of Bucillamine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Bucillamine suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Bucillamine Drug Master File in Korea (Bucillamine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Bucillamine. The MFDS reviews the Bucillamine KDMF as part of the drug registration process and uses the information provided in the Bucillamine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Bucillamine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Bucillamine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Bucillamine suppliers with KDMF on PharmaCompass.
Bucillamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bucillamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bucillamine GMP manufacturer or Bucillamine GMP API supplier for your needs.
A Bucillamine CoA (Certificate of Analysis) is a formal document that attests to Bucillamine's compliance with Bucillamine specifications and serves as a tool for batch-level quality control.
Bucillamine CoA mostly includes findings from lab analyses of a specific batch. For each Bucillamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bucillamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Bucillamine EP), Bucillamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bucillamine USP).
LOOKING FOR A SUPPLIER?
